Kopran Limited (BOM:524280)

Market Cap	5.95B -27.9%
Revenue (ttm)	6.20B -3.7%
Net Income	165.43M -65.2%
EPS	3.42 -65.3%
Shares Out	48.29M
PE Ratio	36.07
Forward PE	n/a
Dividend	3.00 (2.44%)
Ex-Dividend Date	Sep 4, 2025

Volume	11,567
Average Volume	7,276
Open	123.60
Previous Close	123.20
Day's Range	121.35 - 124.70
52-Week Range	119.60 - 214.65
Beta	0.29
RSI	35.74
Earnings Date	May 15, 2026

About Kopran

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, s...

• Industry: Pharmaceutical Preparations
• Founded: 1958
• Employees: 1,024
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524280

Financial Performance

In fiscal year 2025, Kopran's revenue was 6.30 billion, an increase of 2.44% compared to the previous year's 6.15 billion. Earnings were 385.52 million, a decrease of -24.34%.